BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 14665906)

  • 1. Is cytology required for a hematuria evaluation?
    Hofland CA; Mariani AJ
    J Urol; 2004 Jan; 171(1):324-6. PubMed ID: 14665906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine urine cytology has no role in hematuria investigations.
    Mishriki SF; Aboumarzouk O; Vint R; Grimsley SJ; Lam T; Somani B
    J Urol; 2013 Apr; 189(4):1255-8. PubMed ID: 23079371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of atypical urine cytology in a tertiary care center.
    Deshpande V; McKee GT
    Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine cytology in the evaluation of urological malignancy revisited: is it still necessary?
    Falebita OA; Lee G; Sweeney P
    Urol Int; 2010; 84(1):45-9. PubMed ID: 20173368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria].
    Obroniecka I; Rojewska J; Wańkowicz Z
    Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.
    Grossfeld GD; Wolf JS; Litwan MS; Hricak H; Shuler CL; Agerter DC; Carroll PR
    Am Fam Physician; 2001 Mar; 63(6):1145-54. PubMed ID: 11277551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of asymptomatic microscopic hematuria in adults.
    Yamamoto M; Hibi H; Miyake K
    Hinyokika Kiyo; 1993 May; 39(5):413-7. PubMed ID: 8322622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of urinary cytology in women presenting with urge incontinence and/or irritative voiding symptoms.
    Duldulao KE; Diokno AC; Mitchell B
    J Urol; 1997 Jan; 157(1):113-6. PubMed ID: 8976229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
    J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients.
    Feifer AH; Steinberg J; Tanguay S; Aprikian AG; Brimo F; Kassouf W
    Urology; 2010 Jun; 75(6):1278-82. PubMed ID: 20138655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.
    Bartoletti R; Cai T; Dal Canto M; Boddi V; Nesi G; Piazzini M
    J Urol; 2006 Jun; 175(6):2032-7; discussion 2037. PubMed ID: 16697794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria.
    Sudakoff GS; Dunn DP; Guralnick ML; Hellman RS; Eastwood D; See WA
    J Urol; 2008 Mar; 179(3):862-7; discussion 867. PubMed ID: 18221955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
    Gupta NP; Sharma N; Kumar R
    Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice.
    Khadra MH; Pickard RS; Charlton M; Powell PH; Neal DE
    J Urol; 2000 Feb; 163(2):524-7. PubMed ID: 10647670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytology in the assessment of patients with painless gross haematuria.
    Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
    BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
    Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
    Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.